Website Under Maintenance

Newsroom Published Jun 08, 2024 01:50 PM

Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST

By: Kahn Swick & Foti, LLC via Business Wire

May 12, 2021 at 17:31 PM EDT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Acasti Pharma Inc. (“Acasti” or the “Company”) (NasdaqGS: ACST) with Grace Therapeutics Inc., pursuant to which Acasti shareholders will end up owning only approximately 55% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-acst/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210512006042/en/

Contacts

Kahn Swick & Foti, LLC

Lewis S. Kahn

Managing Partner

855-768-1857

lewis.kahn@ksfcounsel.com

Website Under Maintenance

Website Under Maintenance

ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST

Contacts

More News